Clinical trial transparency regulations: Implications to various scholarly publishing stakeholders

Abdul Razack, Habeeb Ibrahim; Aranjani, Jesil Mathew; Mathew, Sam T

doi:10.1093/scipol/scac041

Cited by 3Academic Publishing and Open AccessResearch Data Management PracticesPharmaceutical industry and healthcare

Clinical trial transparency regulations: Implications to various scholarly publishing stakeholders

Abdul Razack, Habeeb Ibrahim, Aranjani, Jesil Mathew, Mathew, Sam T·2022·Science and Public Policy

DOI 10.1093/scipol/scac041

Open this paper in CoChat — free account

Abstract

Abstract As thousands of 2019 Corona virus disease (Covid-19) clinical trials are continuously getting added to various registries these days, good practices on data sharing and transparency have become one of the prime topics of discussion than ever before. Although trial registration is considered a crucial step, there is a lack of integration between registration and published literature. Trial outcomes are a matter of public interest, but sponsor compliances are not adequate with the recommended guidelines. Although the global recognition of data transparency increases day by day, there is still a long journey to travel. It is high time that scholarly publishing stakeholders should put in a collaborative effort to check author compliance. In this article, we aimed to comprehend and discuss the imperative roles of various scholarly publishing stakeholders in improving clinical trial transparency during this pandemic situation and highlight the changing paradigm towards the pressing need for reporting clinical trial data more effectively.

Integrity signals

Registry

Crossref · 10.1093/scipol/scac041

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clear communication of data collection process may lead to privacy concerns.
“May lead to privacy concerns”
From AI Fairness in Data Management and Analytics: A Review on Challenges, Methodologies and Applications (2023) · cites this paper as [250]
Providing information on methods and data use increases data sharing and collaboration.
“Increases data sharing and collaboration”
From AI Fairness in Data Management and Analytics: A Review on Challenges, Methodologies and Applications (2023) · cites this paper as [250]
Providing information on methods and data use has difficulties in balancing transparency.
“Difficulties in balancing transparency”
From AI Fairness in Data Management and Analytics: A Review on Challenges, Methodologies and Applications (2023) · cites this paper as [250]
Clear communication of data collection process builds trust with data subjects.
“Builds trust with data subjects”
From AI Fairness in Data Management and Analytics: A Review on Challenges, Methodologies and Applications (2023) · cites this paper as [250]

Promoting an open research culture
Nosek, B. A., Alter, G., Banks, G. C., Borsboom, D., Bowman, S. D., Breckler, S. J., Buck, S., Chambers, C. D., Chin, G., Christensen, G., et al. (2015) · Science · doi:10.1126/science.aab2374 · Cited by 2,708 · see citing works
Reporting bias in medical research - a narrative review
McGauran, N., Wieseler, B., Kreis, J., Schüler, Y.-B., Kölsch, H., & Kaiser, T. (2010) · Trials · doi:10.1186/1745-6215-11-37 · Cited by 452 · see citing works
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
DeVito, N. J., Bacon, S., & Goldacre, B. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33220-9 · Cited by 336 · see citing works
The citation advantage of linking publications to research data
Colavizza, G., Hrynaszkiewicz, I., Staden, I., Whitaker, K., & McGillivray, B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230416 · Cited by 335 · see citing works
Ten Simple Rules for Creating a Good Data Management Plan
Michener, W. K. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004525 · Cited by 254 · see citing works
Reproducible research and Biostatistics
Peng, R. D. (2009) · Biostatistics · doi:10.1093/biostatistics/kxp014 · Cited by 244 · see citing works
Preserving Clinical Trial Integrity During the Coronavirus Pandemic
McDermott, M. M., & Newman, A. B. (2020) · JAMA · doi:10.1001/jama.2020.4689 · Cited by 193 · see citing works
COVID-19 and readjusting clinical trials
van Dorn, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31787-6 · Cited by 186 · see citing works
Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor
Flacco, M. E., Manzoli, L., Boccia, S., Capasso, L., Aleksovska, K., Rosso, A., Scaioli, G., De Vito, C., Siliquini, R., Villari, P., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.016 · Cited by 177 · see citing works
Data Archiving
Whitlock, M. C., McPeek, M. A., Rausher, M. D., Rieseberg, L. H., & Moore, A. J. (2010) · The American Naturalist · doi:10.1086/650340 · Cited by 169 · see citing works
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
Miller, J. E., Korn, D., & Ross, J. S. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009758 · Cited by 92 · see citing works
High-profile coronavirus retractions raise concerns about data oversight
Ledford, H. K., & Noorden, R. V. (2020) · Nature · doi:10.1038/d41586-020-01695-w · Cited by 88 · see citing works
A systematic literature review of health consumer attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on privacy, trust, and transparency
Hutchings, E., Loomes, M., Butow, P. N., & Boyle, F. M. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01481-9 · Cited by 81 · see citing works
What do we know about India’s Covaxin vaccine?
Thiagarajan, K. (2021) · BMJ · doi:10.1136/bmj.n997 · Cited by 70 · see citing works
Managing clinical trials during COVID-19: experience from a clinical research facility
Shiely, F., Foley, J. D., STONE, A. K., et al. (2021) · Trials · doi:10.1186/s13063-020-05004-8 · Cited by 66 · see citing works
Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study
Woolley, K. L., Lew, R. A., Stretton, S., Ely, J. A., Bramich, N. J., Keys, J. R., Monk, J. A., & Woolley, M. J. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.573546 · Cited by 50 · see citing works
Lay Summaries of Clinical Study Results: An Overview
Barnes, A., & Patrick, S. (2019) · Pharmaceutical Medicine · doi:10.1007/s40290-019-00285-0 · Cited by 47 · see citing works
A data-sharing agreement helps to increase researchers’ willingness to share primary data: results from a randomized controlled trial
Polanin, J. R., & Terzian, M. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.10.006 · Cited by 46 · see citing works
The COVID-19 pandemic and new clinical trial activations
Unger, J. M., & Xiao, H. (2021) · Trials · doi:10.1186/s13063-021-05219-3 · Cited by 46 · see citing works
Understanding Plain English summaries. A comparison of two approaches to improve the quality of Plain English summaries in research reports
Kirkpatrick, E. V., Gaisford, W., Williams, E., Brindley, E., Tembo, D., & Wright, D. N. M. (2017) · Research Involvement and Engagement · doi:10.1186/s40900-017-0064-0 · Cited by 39 · see citing works
Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysis
Spence, O., Hong, K., Onwuchekwa Uba, R., & Doshi, P. (2020) · Clinical Trials · doi:10.1177/1740774519868310 · Cited by 37 · see citing works
Publishers’ Responsibilities in Promoting Data Quality and Reproducibility
Hrynaszkiewicz, I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_290 · Cited by 36 · see citing works
Clinical Trial Data Transparency and GDPR Compliance: Implications for Data Sharing and Open Innovation
Minssen, T., Neethu, R., & Bogers, M. L. A. M. (2019) · Science and Public Policy · doi:10.1093/scipol/scaa014 · Cited by 36 · see citing works
Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study
Gattrell, W. T., Hopewell, S., Young, K., Farrow, P. J., White, R., Wager, E., & Winchester, C. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010329 · Cited by 35 · see citing works
Toward assessing clinical trial publications for reporting transparency
Kilicoglu, H., Rosemblat, G., Hoang, L., Wadhwa, S., Peng, Z., Malički, M., Schneider, J., & ter Riet, G. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103717 · Cited by 34 · see citing works
A Survey of Researchers’ Needs and Priorities for Data Sharing
Hrynaszkiewicz, I., Harney, J., & Cadwallader, L. (2021) · Data Science Journal · doi:10.5334/dsj-2021-031 · Cited by 34 · see citing works
Impact of data transparency: Scientific publications
Joshi, M., & Bhardwaj, P. (2018) · Perspectives in Clinical Research · doi:10.4103/picr.picr_104_17 · Cited by 30 · see citing works
Author attitudes to professional medical writing support
Marchington, J. M., & Burd, G. P. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.939618 · Cited by 24 · see citing works
All trials registered, all results reported
Pierson, C. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12470 · Cited by 24 · see citing works
Declaration of Medical Writing Assistance in International Peer-Reviewed Publications
Woolley, K. L., Ely, J. A., Woolley, M. J., Findlay, L., Lynch, F. A., Choi, Y., & McDonald, J. M. (2006) · JAMA · doi:10.1001/jama.296.8.932-b · Cited by 23 · see citing works
Publishing descriptions of non-public clinical datasets: proposed guidance for researchers, repositories, editors and funding organisations
Hrynaszkiewicz, I., Khodiyar, V., Hufton, A. L., & Sansone, S. (2016) · Research Integrity and Peer Review · doi:10.1186/s41073-016-0015-6 · Cited by 23 · see citing works
FDA and NIH let clinical trial sponsors keep results secret and break the law
(2020) · AAAS Articles DO Group · doi:10.1126/science.aba8123 · Cited by 20 · see citing works
Transparency and objectivity in governance of clinical trials data sharing: Current practices and approaches
Shabani, M., & Obasa, M. (2019) · Clinical Trials · doi:10.1177/1740774519865517 · Cited by 19 · see citing works
Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help!
Hamilton, C. W., Gertel, A., Jacobs, A., Marchington, J. M., Weaver, S., & Woolley, K. L. (2015) · Accountability in Research · doi:10.1080/08989621.2015.1088788 · Cited by 18 · see citing works
Declining the Transparency and Openness Promotion Guidelines
Lash, T. L. (2015) · Epidemiology · doi:10.1097/ede.0000000000000382 · Cited by 17 · see citing works
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
Axson, S. A., Mello, M. M., Lincow, D., Yang, C. F., Gross, C. P., Ross, J. S., & Miller, J. E. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053248 · Cited by 17 · see citing works
Secondary Analysis of Clinical Trials—A Cautionary Note
Marler, J. R. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2011.09.006 · Cited by 16 · see citing works
Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy
Penlington, M., Goulet, P., & Metcalfe, B. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.12.045 · Cited by 16 · see citing works
American Heart Association
McInroy, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-39903-0_1207 · Cited by 16 · see citing works
Lack of Transparency in Publishing Negative Clinical Trial Results
Snyder, R. (2020) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2019.12.013 · Cited by 15 · see citing works
Money and Morals
Eaton, M. L., Kwon, B. K., & Scott, C. T. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_337 · Cited by 13 · see citing works
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Baróniková, S., Purvis, J., Southam, E., Beeso, J., Winchester, C., & Panayi, A. (2019) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-111145 · Cited by 13 · see citing works
The Open Data Challenge: An Analysis of 124,000 Data Availability Statements and an Ironic Lesson about Data Management Plans
Graf, C., Flanagan, D., Wylie, L., & Silver, D. (2020) · Data Intelligence · doi:10.1162/dint_a_00061 · Cited by 13 · see citing works
Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Evuarherhe, O., Gattrell, W. T., White, R., & Winchester, C. (2019) · Research Integrity and Peer Review · doi:10.1186/s41073-019-0073-7 · Cited by 10 · see citing works
Plain Language Summaries of Clinical Trial Results: A Preliminary Study to Assess Availability of Easy-to-Understand Summaries and Approaches to Improving Public Engagement
Penlington, M., Silverman, H. I., Vasudevan, A., & Pavithran, P. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00359-4 · Cited by 9 · see citing works
Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors
Taichman, D. B., ‎Sahni, P., Pinborg, A. B., Peiperl, L., Laine, C. M., James, A., Hong, S., Haileamlak, A., Gollogly, L., Godlee, F., et al. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.17.196733 · Cited by 8 · see citing works
The clinical trial transparency in oncology significantly increased over the recent years
Song, S. Y., & Kim, E. Y. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.11.018 · Cited by 8 · see citing works
A Disclosure Form for Work Submitted to Medical Journals: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3933 · Cited by 8 · see citing works
Professional Medical Writer Assistance in Oncology Clinical Trials
Kouzy, R., Jaoude, J. A., Mainwaring, W., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0406 · Cited by 8 · see citing works
Professional medical writing support and the reporting quality of randomized controlled trial abstracts among high-impact general medical journals
Mills, I., Sheard, C., Hays, M., Douglas, K., Winchester, C., & Gattrell, W. T. (2017) · F1000Research · doi:10.12688/f1000research.12268.2 · Cited by 6 · see citing works
Professional writers can help to improve clarity of medical writing
Donnelly, J. A., Marchington, J. M., Gertel, A., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.68670 · Cited by 6 · see citing works
Reporting null results and advancing science
Petty, S., & Gross, R. A. (2019) · Neurology · doi:10.1212/wnl.0000000000007400 · Cited by 6 · see citing works
Government regulators must steward drug transparency
Herder, M. (2014) · Nature Medicine · doi:10.1038/nm0814-806 · Cited by 5 · see citing works
Appropriate Clinical Trial Registration Is the Key to Transparent Reporting and Publication
Fujii, S., & Bainbridge, D. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.01.005 · Cited by 4 · see citing works
Who writes dermatology randomized controlled trials? The need to specify the role of medical writers
Steele, L., Lee, H. L., Earp, E., et al. (2021) · Clinical and Experimental Dermatology · doi:10.1111/ced.14711 · Cited by 4 · see citing works
Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors
Mooney, L. A., Fay, L., DeCastro, B., Zanki, T. A., & Mansi, B. A. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1570770 · Cited by 3 · see citing works
Supporting data sharing
Kirk, R., & Norton, L. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0103-0 · Cited by 3 · see citing works
Randomized Clinical Trials in the Era of Precision Oncology—The Role of End Points, Industry Funding, and Medical Writing Integrity
Schindler, T. M., Marchington, J. M., & Flores, G. V. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3341 · Cited by 3 · see citing works
Health Policy Brief: Transparency In Clinical Research
(2016) · Forefront Group · doi:10.1377/forefront.20160118.052727 · Cited by 3 · see citing works
Implications of clinical trial data sharing for medical writers
Ross, J. S., & Krumholz, H. M. (2013) · Medical Writing · doi:10.1179/2047480612z.00000000085 · Cited by 1 · see citing works
Managing Conflict of Interest Disclosure—Where Are We Going?
Kunz, A. (2019) · Science Editor · doi:10.36591/se-4203-11 · Cited by 1 · see citing works

Flagged first, then by citations

Sorted by citations

AI Fairness in Data Management and Analytics: A Review on Challenges, Methodologies and Applications
Chen, P., Wu, L., & Wang, L. (2023) · Applied Sciences · doi:10.3390/app131810258 · Cited by 155 · see citing works

Authors: Abdul Razack, H. I., Aranjani, J. M., & Mathew, S. T.
Affiliations: Faculty of Medicine & Health Sciences, University of Putra Malaysia , Serdang, Selangor 43400, Malaysia
Manipal Academy of Higher Education (IN)
Researcher & Medical Communications Expert , Flat No. 123, Mahaveer Rhyolite, Bengaluru, Karnataka 560076, India
Corresponding author: Mathew, Sam T
ORCID: Abdul Razack, Habeeb Ibrahim
Aranjani, Jesil Mathew
Mathew, Sam T
Venue: Science and Public Policy
Publisher: Oxford University Press (OUP)
Published: 2022-08-03
Volume: 49
Issue: 6
Pages: 951-961
ISSN: 0302-3427 (ISSN-L)
1471-5430
DOI: 10.1093/scipol/scac041
OpenAlex: W4289549996
Cited by: 3
References: 61
Citations by year: 2025: 1 · 2023: 2
FWCI: 0.63
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Science and Public Policy (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Social Sciences › Decision Sciences › Information Systems and Management › Academic Publishing and Open Access
Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
Keywords: clinical trial transparency, clinical trial registration, data sharing, reporting guidelines, author compliance, COVID-19 clinical trials, clinical trial registries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical trial transparency regulations: Implications to various scholarly publishing stakeholders

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks